Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

N95 respirators for H1N1 protection

This article was originally published in The Gray Sheet

Executive Summary

The American Hospital Association in a Sept. 15 letter requests that the Centers for Disease Control and Prevention reconsider its recommendations that health care workers caring for H1N1 influenza victims wear fit-tested N95 respirators, "given the limited supply of N95 respirators." To date, the virus "has not changed to become more severe" than seasonal influenza, AHA says. CDC issued the call for fit-tested N95 respirators earlier this month as a precaution, because it is still unknown if the H1N1 virus spreads through personal contact, droplet spray or airborne transmission ("1The Gray Sheet" Sept. 14, 2009)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027941

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel